FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

5 results

herceptin
(Trastuzumab)
Genentech, Inc.
Usage: Herceptin is indicated for the adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer in combination with paclitaxel, or as a single agent after previous regimens. It is also used with cisplatin and capecitabine for HER2-positive metastatic gastric cancer. Patient selection should utilize an FDA-approved diagnostic.
herceptin hylecta
(Trastuzumab and hyaluronidase-oysk)
Genentech, Inc.
Usage: HERCEPTIN HYLECTA is indicated for adjuvant treatment of HER2 overexpressing breast cancer in adults, either as part of a combination regimen with specific chemotherapy agents or as a single agent after anthracycline-based therapy. It is also used for first-line and subsequent treatment of metastatic breast cancer.
herzuma
(TRASTUZUMAB)
Cephalon, Inc.
Usage: HERZUMA is indicated for adults with HER2 overexpressing breast cancer, both in adjuvant and metastatic settings, and for metastatic gastric or gastroesophageal junction adenocarcinoma. Treatment modalities include combinations with specific chemotherapies or as a single agent, guided by FDA-approved diagnostics.
trazimera
(trastuzumab-qyyp)
Pfizer Laboratories Div Pfizer Inc
Usage: TRAZIMERA is indicated for adjuvant treatment of HER2-overexpressing breast cancer (both node-positive and node-negative) and for metastatic breast cancer (in combination with paclitaxel or as a single agent). It is also indicated for HER2-overexpressing metastatic gastric cancer, used with cisplatin and capecitabine or 5-fluorouracil.
tykerb
(lapatinib)
Novartis Pharmaceuticals Corporation
Usage: TYKERB® is indicated for advanced or metastatic breast cancer in combination with capecitabine for HER2-overexpressing tumors after prior therapies, and with letrozole for postmenopausal women with hormone receptor-positive, HER2-overexpressing metastatic breast cancer where hormonal therapy is appropriate. Prior progression on trastuzumab is required.

Medications for Metastatic Malignant Breast Neoplasm

herceptin

herceptin hylecta

herzuma

trazimera

tykerb